Acuity officer plans $659K sale of 2,000 shares

Rhea-AI Filing Summary

ACUITY INC. (DE) (AYI) is the issuer of common stock that officer Karen Holcom has filed to sell under Rule 144. The notice covers 2,000 shares of common stock to be sold through Merrill Lynch on the NYSE, with an indicated value of $659,240.00.

Key Figures

Shares to be sold under Rule 144: 2,000 shares of common stock Indicated value of planned sale: $659,240.00 Shares sold in past three months: 2,076 shares of common stock +4 more

7 metrics

Shares to be sold under Rule 144 2,000 shares of common stock Planned sale through Merrill Lynch on NYSE as of 09/01/2026

Indicated value of planned sale $659,240.00 Value associated with 2,000 shares of common stock as of 09/01/2026

Shares sold in past three months 2,076 shares of common stock Sold on 06/01/2026 by Karen Holcom

Proceeds from recent sale $629,318.64 Sale of 2,076 shares on 06/01/2026

RSU vesting 03/01/2023 164 shares of common stock Vesting of restricted stock unit awards granted under equity compensation plan

RSU vesting 10/24/2023 984 shares of common stock Vesting of restricted stock unit awards granted under equity compensation plan

RSU vesting 10/24/2024 852 shares of common stock Vesting of restricted stock unit awards granted under equity compensation plan

Key Terms

Rule 144, restricted stock unit awards, equity compensation plan

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock unit awards financial

"Vesting of restricted stock unit awards | ACUITY INC. (DE)"

Restricted stock unit awards are company promises to deliver a specific number of shares to employees or service providers in the future once conditions—such as staying with the company for a set time or meeting performance targets—are met. They matter to investors because when the promises convert into actual shares they increase the total share count and can reduce earnings per share, while also aligning recipients’ interests with stock performance much like deferred pay that turns into ownership if goals are met.

equity compensation plan financial

"Granted as part of issuer equity compensation plan"

A plan by which a company gives employees, directors or contractors ownership or the right to buy ownership in the company through stock, options or similar awards — think of promising slices of the company pie as part of someone's pay. It matters to investors because these awards can change the number of shares outstanding, affect reported profits and influence management’s decisions; large or generous plans can dilute existing holders and alter incentives over time.

FAQ

How many AYI shares does Karen Holcom plan to sell under this Rule 144 notice?

Karen Holcom filed to sell 2,000 shares of ACUITY INC. (DE) common stock under Rule 144, to be transacted through Merrill Lynch on the NYSE with an indicated value of $659,240.00 as of 09/01/2026.

What prior AYI stock sale did Karen Holcom report in the past three months?

In the past three months, Karen Holcom reported selling 2,076 shares of ACUITY INC. (DE) common stock on 06/01/2026 for total proceeds of $629,318.64.

What equity awards for AYI vested for Karen Holcom that relate to these securities?

The securities relate to vested restricted stock unit awards of ACUITY INC. (DE) common stock: 164 shares vested on 03/01/2023, 984 shares on 10/24/2023, and 852 shares on 10/24/2024, all granted under the issuer’s equity compensation plan.

Which broker is handling Karen Holcom’s planned AYI stock sale?

The planned sale of 2,000 shares of ACUITY INC. (DE) common stock is to be handled by Merrill Lynch, located at 225 Liberty Street, Floor 37, New York, NY 10281, with trading on the NYSE.

On what date is the AYI Rule 144 sale information indicated?

The Rule 144 sale information for the 2,000 AYI shares carries a date of 09/01/2026, which is associated with the planned NYSE transaction value of $659,240.00.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/01/2026 - 04:14 PM Accepted by SEC EDGAR 09/01/2026 - 04:14 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001302261
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ACUITY INC. (DE)
SEC File Number	001-16583
Address of Issuer	1170 PEACHTREE STREET NE SUITE 1200 ATLANTA GEORGIA 30309
Phone	404-853-1400
Name of Person for Whose Account the Securities are To Be Sold	HOLCOM KAREN J
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 225 Liberty Street Floor 37 New York NY 10281	2000	659240.00	29935547	09/01/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/01/2023	Vesting of restricted stock unit awards	ACUITY INC. (DE)			164	03/01/2023	Granted as part of issuer equity compensation plan
Common Stock	10/24/2023	Vesting of restricted stock unit awards	ACUITY INC. (DE)			984	10/24/2023	Granted as part of issuer equity compensation plan
Common Stock	10/24/2024	Vesting of restricted stock unit awards	ACUITY INC. (DE)			852	10/24/2024	Granted as part of issuer equity compensation plan

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Karen Holcom 1170 PEACHTREE STREET NE SUITE 1200 ATLANTA GA 30309	Common Stock	06/01/2026	2076	629318.64

144: Remarks and Signature

Remarks
Date of Notice	09/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	10/29/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Karen Holcom
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)